Clancy Paul J has filed 22 insider transactions across 4 companies since December 2023.
Most recent transaction: a grant/award of 265 shares of INCYTE CORP ($INCY) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 265 | $94.12 | 23,741.0000 | 200,700,000 | 1.13% | 0.00% |
| March 23, 2026 | EXACT SCIENCES CORP | $EXAS | Clancy Paul J | Not found | D | Common Stock | 5398 | $0.00 | 0.0000 | 190,888,211 | 100.00% | 0.00% |
| March 23, 2026 | EXACT SCIENCES CORP | $EXAS | Clancy Paul J | Not found | D | Common Stock | 20640 | $0.00 | 5,398.0000 | 190,888,211 | 79.27% | 0.01% |
| Dec. 31, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 241 | $98.77 | 23,476.0000 | 201,429,000 | 1.04% | 0.00% |
| Sept. 30, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 285 | $84.81 | 23,235.0000 | 210,530,000 | 1.24% | 0.00% |
| June 30, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 361 | $68.10 | 22,950.0000 | 210,530,000 | 1.60% | 0.00% |
| June 12, 2025 | EXACT SCIENCES CORP | $EXAS | Clancy Paul J | Not found | A | Common Stock | 5398 | $0.00 | 26,038.0000 | 185,755,406 | 26.15% | 0.00% |
| June 12, 2025 | Sionna Therapeutics, Inc. | $SION | Clancy Paul J | Director | A | Non-Qualified Stock Option (right to buy) | 19959 | $0.00 | 19,959.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 2518 | $0.00 | 22,589.0000 | 210,530,000 | 12.55% | 0.00% |
| June 11, 2025 | Xilio Therapeutics, Inc. | $XLO | Clancy Paul J | Not found | A | Stock Option (right to buy) | 31000 | $0.00 | 31,000.0000 | 63,465,063 | 9999.99% | 0.05% |
| June 10, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| March 31, 2025 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 358 | $60.55 | 20,071.0000 | 210,530,000 | 1.82% | 0.00% |
| Dec. 31, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 331 | $69.07 | 19,713.0000 | 211,763,000 | 1.71% | 0.00% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | Clancy Paul J | Not found | A | Common Stock | 5939 | $0.00 | 20,640.0000 | 0 | 40.40% | 0.00% |
| Sept. 30, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 368 | $66.10 | 19,382.0000 | 225,928,000 | 1.94% | 0.00% |
| June 28, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 399 | $60.62 | 19,014.0000 | 225,928,000 | 2.14% | 0.00% |
| June 14, 2024 | Xilio Therapeutics, Inc. | $XLO | Clancy Paul J | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | Clancy Paul J | Not found | A | Common Stock | 5444 | $0.00 | 20,145.0000 | 0 | 37.03% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 2830 | $0.00 | 18,615.0000 | 225,928,000 | 17.93% | 0.00% |
| March 28, 2024 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 403 | $56.97 | 15,785.0000 | 225,928,000 | 2.62% | 0.00% |
| Dec. 29, 2023 | INCYTE CORP | $INCY | Clancy Paul J | Director | A | Common Stock | 412 | $62.79 | 15,382.0000 | 223,958,000 | 2.75% | 0.00% |